Paul M. Harari

26.2k total citations · 6 hit papers
303 papers, 18.1k citations indexed

About

Paul M. Harari is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Paul M. Harari has authored 303 papers receiving a total of 18.1k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Pulmonary and Respiratory Medicine, 131 papers in Oncology and 123 papers in Otorhinolaryngology. Recurrent topics in Paul M. Harari's work include Head and Neck Cancer Studies (123 papers), Lung Cancer Treatments and Mutations (75 papers) and Advanced Radiotherapy Techniques (44 papers). Paul M. Harari is often cited by papers focused on Head and Neck Cancer Studies (123 papers), Lung Cancer Treatments and Mutations (75 papers) and Advanced Radiotherapy Techniques (44 papers). Paul M. Harari collaborates with scholars based in United States, Germany and Spain. Paul M. Harari's co-authors include Shyhmin Huang, James A. Bonner, S. Huang, David Raben, J. Giralt, Eric A. Armstrong, Christopher U. Jones, José Baselga, Roger B. Cohen and Eric K. Rowinsky and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Paul M. Harari

294 papers receiving 17.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

2006 3.7k citations James A. Bonner, Paul M. Harari et al. profile →
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

2009 1.4k citations James A. Bonner, Paul M. Harari et al. profile →
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

1999 581 citations S. Huang, Paul M. Harari et al. profile →
Understanding resistance to EGFR inhibitors—impact on future treatment strategies

2010 540 citations Deric L. Wheeler, Paul M. Harari et al. profile →
Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer

2013 293 citations Randall J. Kimple, Molly A. Smith et al. Cancer Research profile →
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma

2014 289 citations Paul M. Harari, David Raben et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Paul M. Harari

Since Specialization

Citations

This map shows the geographic impact of Paul M. Harari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Harari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Harari more than expected).

Fields of papers citing papers by Paul M. Harari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Harari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Harari. The network helps show where Paul M. Harari may publish in the future.

Co-authorship network of co-authors of Paul M. Harari

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Harari. A scholar is included among the top collaborators of Paul M. Harari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Harari. Paul M. Harari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti‐PDL1 efficacy in head and neck cancer 2023 ·Head & Neck ·(unknown), Mari Iida, (unknown), Stanley Kimani, (unknown), (unknown), (unknown), Menggang Yu, Seungpyo Hong, Ravi Salgia, Justine Y. Bruce, Raymond B. Birge, Paul M. Harari, Deric L. Wheeler	7
2	Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade 2022 ·Clinical Cancer Research ·Wei Wang, (unknown), (unknown), Denis Lee, (unknown), (unknown), Mitchell Hayes, Justine Y. Bruce, Randall J. Kimple, Rong Hu, Paul M. Harari, Jin Xu, (unknown), Paul M. Sondel, Megan B. Fitzpatrick, Huy Q. Dinh, Paul F. Lambert	22
3	Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers 2020 ·Cancers ·Aadhya Tiwari, Mari Iida, Corinna Kosnopfel, (unknown), Apostolos Menegakis, Birgit Fehrenbacher, Julia Maier, Martin Schaller, Sara Y. Brucker, Deric L. Wheeler, Paul M. Harari, Ulrich Rothbauer, Birgit Schittek, Daniel Zips, Mahmoud Toulany	17
4	Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog 2018 ·Molecular Cancer Therapeutics ·(unknown), (unknown), (unknown), Dana C. Baiu, Chunrong Li, Lauryn R. Werner, (unknown), Lance T. Hall, Jamey P. Weichert, Eric A. Armstrong, Bryan P. Bednarz, Paul M. Harari, Gopal Iyer, Mario Otto	4
5	Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites 2018 ·Cancer Immunology Research ·Zachary S. Morris, (unknown), Lauryn R. Werner, Peter M. Carlson, (unknown), Jasdeep S. Kler, (unknown), (unknown), Raghava N. Sriramaneni, Lakeesha Carmichael, Hans Loibner, Stephen D. Gillies, Alan J. Korman, Amy K. Erbe, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Paul M. Harari, Paul M. Sondel	54
6	MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents 2018 ·Molecular Cancer Therapeutics ·(unknown), Christopher T. Cummings, Mari Iida, (unknown), (unknown), (unknown), Rebecca E. Parker, (unknown), (unknown), (unknown), (unknown), Kurtis D. Davies, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Paul M. Harari, Randall J. Kimple, Deborah DeRyckere, Douglas K. Graham, Deric L. Wheeler	41
7	Methadone Use During Concurrent Chemoradiation in Patients With Head and Neck Cancer 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Justine Y. Bruce, (unknown), Kaitlin M. Woo, Menggang Yu, (unknown), Matthew E. Witek, Paul M. Harari, Randall J. Kimple	0
8	Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition 2017 ·Clinical Cancer Research ·(unknown), (unknown), Adam D. Swick, Lauryn R. Werner, Kwangok P. Nickel, Emmanuel Sampene, Rong Hu, Irene M. Ong, Justine Y. Bruce, Gregory K. Hartig, Aaron M. Wieland, Jude Canon, Paul M. Harari, Randall J. Kimple	21
9	In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments 2016 ·Cancer Research ·Zachary S. Morris, (unknown), David M. Francis, (unknown), Lauryn R. Werner, Lakeesha Carmichael, Richard K. Yang, Eric A. Armstrong, Shyhmin Huang, Fariba Navid, Stephen D. Gillies, Alan J. Korman, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Paul M. Harari, Paul M. Sondel	119
10	Small Molecule Inhibition of MDM2–p53 Interaction Augments Radiation Response in Human Tumors 2015 ·Molecular Cancer Therapeutics ·Lauryn R. Werner, Shyhmin Huang, David M. Francis, Eric A. Armstrong, Fang Ma, Chunrong Li, Gopal Iyer, Jude Canon, Paul M. Harari	40
11	Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers 2015 ·Molecular Cancer Therapeutics ·Chunrong Li, Shyhmin Huang, Eric A. Armstrong, David M. Francis, Lauryn R. Werner, Mark X. Sliwkowski, Albert van der Kogel, Paul M. Harari	26
12	Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab 2015 ·Journal of Clinical Oncology ·David I. Rosenthal, Paul M. Harari, J. Giralt, Diana Bell, David Raben, Joyce F. Liu, Jeltje Schulten, Kian Ang, James A. Bonner	150
13	Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer breakdown → 2013 ·Cancer Research ·Randall J. Kimple, Molly A. Smith, Grace C. Blitzer, Alexandra D. Torres, Joshua A. Martin, Robert Yang, Chimera R. Peet, Laurel D. Lorenz, Kwangok P. Nickel, Aloysius J. Klingelhutz, Paul F. Lambert, Paul M. Harari	293
14	Sym004, a Novel Anti-EGFR Antibody Mixture, Augments Radiation Response in Human Lung and Head and Neck Cancers 2013 ·Molecular Cancer Therapeutics ·Shyhmin Huang, Chimera R. Peet, Jarob Saker, Chunrong Li, Eric A. Armstrong, Michael Kragh, Mikkel W. Pedersen, Paul M. Harari	12
15	Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation 2012 ·Cancer Research ·Shyhmin Huang, Chunrong Li, Eric A. Armstrong, Chimera R. Peet, Jarob Saker, Lukas C. Amler, Mark X. Sliwkowski, Paul M. Harari	150
16	Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts 2012 ·Clinical Cancer Research ·Randall J. Kimple, Paul M. Harari, Alexandra D. Torres, Robert Yang, (unknown), Menggang Yu, Eric A. Armstrong, Grace C. Blitzer, Molly A. Smith, Laurel D. Lorenz, Denis Lee, David T. Yang, Timothy M. McCulloch, Gregory K. Hartig, Paul F. Lambert	78
17	p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation 2011 ·Cancer Research ·Shyhmin Huang, Sergi Benavente, Eric A. Armstrong, Chunrong Li, Deric L. Wheeler, Paul M. Harari	95
18	Augmentation of Radiation Response by Motesanib, a Multikinase Inhibitor that Targets Vascular Endothelial Growth Factor Receptors 2010 ·Clinical Cancer Research ·Tim J. Kruser, Deric L. Wheeler, Eric A. Armstrong, Mari Iida, Kevin R. Kozak, Albert J. van der Kogel, Johan Bussink, Angela Coxon, Anthony Polverino, Paul M. Harari	13
19	Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells 2009 ·Clinical Cancer Research ·Sergi Benavente, Shyhmin Huang, Eric A. Armstrong, Alexander Chi, (unknown), Deric L. Wheeler, Paul M. Harari	73
20	Modulating radiation response with the histone deacetylase (HDAC) inhibitor SAHA in human carcinomas 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Prakash Chinnaiyan, Geetha D. Vallabhaneni, Eric A. Armstrong, S. Huang, Paul M. Harari	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact